Repro-Med Systems, Inc. (KRMD)
Market Cap | 225.87M |
Revenue (ttm) | 26.34M |
Net Income (ttm) | -457,692 |
Shares Out | 43.91M |
EPS (ttm) | -0.02 |
PE Ratio | n/a |
Forward PE | 55.25 |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 20 |
Last Price | $5.14 |
Previous Close | $5.43 |
Change ($) | -0.29 |
Change (%) | -5.34% |
Day's Open | 5.41 |
Day's Range | 5.12 - 5.49 |
Day's Volume | 310,918 |
52-Week Range | 3.78 - 12.42 |
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President and Chief Execut...
Repro Med Systems (KRMD) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that its Board of Directors has authorized a s...
Repro Med Systems, Inc.'s (KRMD) CEO Donald Pettigrew on Q3 2020 Results - Earnings Call Transcript
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the third quarter ended ...
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for...
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc.
Repro Med Systems, Inc.'s (KRMD) CEO Don Pettigrew on Q2 2020 Results - Earnings Call Transcript
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc.
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc.
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical”) today announced the appointment of Josh Bennett to the newly created position...
KORU Is Getting Tailwind From A Shift Away From IV And The Pandemic
Repro Med Systems, Inc. (KRMD) CEO Don Pettigrew on Q1 2020 Results - Earnings Call Transcript
KORU Medical Systems (KRMD) CEO Don Pettigrew on Q4 2019 Results - Earnings Call Transcript
About KRMD
Repro Med Systems, doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The compan... [Read more...]
Industry Medical Instruments & Supplies | Founded 1980 |
CEO Donald B. Pettigrew | Employees 71 |
Stock Exchange NASDAQ | Ticker Symbol KRMD |
Financial Performance
In 2019, KRMD's revenue was $23.16 million, an increase of 33.47% compared to the previous year's $17.35 million. Earnings were $564,349, a decrease of -38.02%.
Analyst Forecasts
According to 4 analysts, the average rating for KRMD stock is "Buy." The 12-month stock price forecast is 11.25, which is an increase of 118.87% from the latest price.